Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
Oct 02, 2024
The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.
https://www.nytimes.com/2024/10/02/health/alzheimers-simufilam-cassava-sciences.html
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service